Petros Pharma stockholders OK reverse stock split up to 1:25

Petros Pharmaceuticals, Inc.

Directors Silverman, Bernstein, Walker elected to one-year terms.
Reverse stock split (range 1:2 to 1:25, Board discretion) approved; For 2,949,518, Against 1,350,781.
Marcum LLP ratified as independent auditor for FY2024 with 3,984,099 for votes.
Advisory say-on-pay proposal passed with 1,433,687 for votes.
Adjournment proposal passed to allow further proxy solicitation if needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.